Adaptive Radiotherapy in Patients With Gynecological Tumors

Launched by UNIVERSITY HOSPITAL, ESSEN · Jan 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a type of treatment called adaptive radiotherapy for women with certain types of advanced gynecological cancers, such as cervical or endometrial cancer. The goal is to see if this tailored approach to radiation therapy can improve the effectiveness of treatment for patients who cannot undergo surgery or other therapies. The trial is currently recruiting participants who are generally healthy, as indicated by their performance status, and who have been diagnosed with these cancers.

To participate, women aged 65 to 74 who have not had prior radiation therapy in the pelvic area and have specific types of tumors may be eligible. If you join the trial, you can expect to receive radiation treatment that is adjusted based on your individual needs, which may help in targeting the tumor more effectively. It’s important to know that this study is focused on finding better treatment options for patients who may not have many choices left, and your involvement could contribute to important advancements in cancer care.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • ECOG 0-1 confirmation by histophatology MR of the pelvis staging
• Exclusion Criteria:
• • Recurrent disease Prior Radiotherapy in pelvic region stage pM1 or cM1